- Trials with a EudraCT protocol (1,074)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1,074 result(s) found for: Cream.
Displaying page 2 of 54.
EudraCT Number: 2008-002317-40 | Sponsor Protocol Number: 280210BS | Start Date*: 2008-10-17 | |||||||||||
Sponsor Name:Perrigo Israel Pharmaceuticals Ltd. | |||||||||||||
Full Title: A phase IIa, multi-center, randomized, double-blind, vehicle-controlled study to determine antipsoriatic efficacy and safety of topical CEP-701 (lestaurtinib) cream formulations in patients with ps... | |||||||||||||
Medical condition: Chronic plaque type psoriasis of mild to moderate severity, at least one plaque with a treatment area of approximately 25 - 50 cm2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005594-36 | Sponsor Protocol Number: PHT/2014/107 | Start Date*: 2015-12-15 | |||||||||||
Sponsor Name:Portsmouth Hospitals NHS Trust | |||||||||||||
Full Title: A Phase IV, Randomised, Double-Blind, Controlled, Parallel Group Trial to Evaluate the Effectiveness and Safety of Balneum Plus vs Emollient in the Treatment of Uraemic Pruritus in Haemodialysis Pa... | |||||||||||||
Medical condition: Uraemic Pruritus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000336-28 | Sponsor Protocol Number: CASM981N2301 | Start Date*: 2006-06-22 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A 52-week open-label, single-arm, multi-center study to evaluate the long term safety of pimecrolimus 1% cream intermittent treatment of seborrhoeic dermatitis in patients 12 years of age and older | ||
Medical condition: Seborrhoeic dermatitis (SD) | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-024623-24 | Sponsor Protocol Number: IPDTAKOTR/V04/24.09.11 | Start Date*: 2011-11-30 | |||||||||||
Sponsor Name:Medizinische Universität Wien, Univ. Klinik f. Dermatologie | |||||||||||||
Full Title: Topical imiquimod 5% cream therapy versus photodynamic therapy with methyl-aminolaevulinate 16% cream of actinic keratoses in organ transplant recipients | |||||||||||||
Medical condition: actinic keratoses | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000253-30 | Sponsor Protocol Number: LP0075-34 | Start Date*: 2012-11-08 | |||||||||||
Sponsor Name:LEO Pharma A/S | |||||||||||||
Full Title: An exploratory study evaluating the efficacy of cromoglicate cream compared to cream vehicle in the treatment of itch in psoriasis | |||||||||||||
Medical condition: itchy psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000404-37 | Sponsor Protocol Number: LP0133-1181 | Start Date*: 2021-04-14 |
Sponsor Name:LEO Pharma A/S | ||
Full Title: A phase 1 open-label, multi-centre, single-arm trial to evaluate the safety and pharmacokinetics (including MUsT) of twice daily topical application of delgocitinib cream for 8 weeks in adults, ado... | ||
Medical condition: Atopic Dermatitis (AD) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2021-006340-27 | Sponsor Protocol Number: LP0133-1426 | Start Date*: 2022-04-21 | |||||||||||
Sponsor Name:LEO Pharma A/S | |||||||||||||
Full Title: A phase 3 clinical trial to evaluate efficacy and safety of twice daily applications of delgocitinib cream 20 mg/g compared with cream vehicle for a 16-week treatment period in adolescents 12-17 ye... | |||||||||||||
Medical condition: Chronic Hand Eczema | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) ES (Ongoing) BE (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023789-33 | Sponsor Protocol Number: 300904BS | Start Date*: 2011-02-17 | |||||||||||
Sponsor Name:Valderm ApS | |||||||||||||
Full Title: A phase IIa, multicenter, randomized, two-arm, observer-blind, vehicle and reference controlled proof of concept trial to investigate intra-individually (left/ right) the antipsoriatic efficacy and... | |||||||||||||
Medical condition: Male or female subjects with stable plaque psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001971-38 | Sponsor Protocol Number: HARRAS1/2006 | Start Date*: 2012-01-05 |
Sponsor Name:HARRAS-PHARMA-CURARINA GmbH | ||
Full Title: Comparative Study with a Propolis Cream vs. Aciclovir Cream in Patients with Herpes labialis A single-blind, randomised, two-arm study | ||
Medical condition: Herpes labialis Single-blind, randomised, controlled parallel group comparison of a Propolis special extract GH 2002 cream (Herpetino® Balsam) and an aciclovir 5% containing cream. Up to 10 day... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004188-38 | Sponsor Protocol Number: PHX401-14 | Start Date*: 2017-12-14 | |||||||||||
Sponsor Name:LABORATOIRE INNOTECH INTERNATIONAL | |||||||||||||
Full Title: Contraceptive Efficacy, Tolerance and Acceptability of A Benzalkonium Chloride Spermicide Cream In Women Aged Over 40 Years of Age - PHASE IV, INTERNATIONAL, OPEN-LABEL, MULTICENTRE, PROSPECTIVE STUDY | |||||||||||||
Medical condition: The current study is conducted in adult women over 40 years of age who need a contraceptive method and who accept to use a spermicide, according to the following inclusion/exclusion criteria and af... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021193-11 | Sponsor Protocol Number: HT-07 | Start Date*: 2010-09-14 | |||||||||||
Sponsor Name:Helperby Thearapeutics Ltd | |||||||||||||
Full Title: A randomised, open-labelled, multiple dose study of HT61 formulations applied to the anterior nares plus chlorhexidine body and hair washes in subjects with nasal carriage of Staphylococcus aureus | |||||||||||||
Medical condition: Nasal carriage of Staphylococcus aureus (including MRSA) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004648-54 | Sponsor Protocol Number: ASF-1057-302 | Start Date*: 2007-12-10 |
Sponsor Name:Astion Pharma A/S | ||
Full Title: Efficacy and safety of ASF-1057 cream 0.5% in the treatment of seborrhoeic dermatitis: A phase III randomised, multi-centre, double-blind, active comparator (ketoconazole cream 2%) and placebo cont... | ||
Medical condition: Seborrhoeic dermatitis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002960-30 | Sponsor Protocol Number: LP0133-1401 | Start Date*: 2021-06-15 |
Sponsor Name:LEO Pharma A/S | ||
Full Title: A phase 3 clinical trial to confirm efficacy and evaluate safety of twice-daily delgocitinib cream 20 mg/g compared with cream vehicle for a 16-week treatment period in adult subjects with moderate... | ||
Medical condition: Chronic Hand Eczema | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) PL (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-002961-32 | Sponsor Protocol Number: LP0133-1402 | Start Date*: 2021-07-01 |
Sponsor Name:LEO Pharma A/S | ||
Full Title: A phase 3 clinical trial to confirm efficacy and evaluate safety of twice-daily delgocitinib cream 20 mg/g compared with cream vehicle for a 16-week treatment period in adult subjects with moderate... | ||
Medical condition: Chronic Hand Eczema | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) DK (Completed) BE (Completed) PL (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-002705-38 | Sponsor Protocol Number: 1/2008 | Start Date*: 2009-03-20 |
Sponsor Name:HARRAS Pharma Curarina Arzneimittel GmbH | ||
Full Title: Double-randomized and controlled clinical trial in children to assess the efficacy and safety of Symphytum herb extract cream 10% against 1% in the acceleration of wound healing | ||
Medical condition: Wound healing | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001469-42 | Sponsor Protocol Number: 35328 | Start Date*: 2011-06-27 |
Sponsor Name:Deventer Ziekenhuis | ||
Full Title: A randomised clinical trial on the effectiveness of MediHoney barrier cream versus the standard therapy with zinc oxide in the treatment of intertrigo. | ||
Medical condition: intertrigo | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002687-14 | Sponsor Protocol Number: FUC 0301 INT | Start Date*: 2004-11-15 | |||||||||||
Sponsor Name:LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S) | |||||||||||||
Full Title: Fucidin® Cream in the Treatment of Impetigo A phase IV study comparing clinical and bacteriological efficacy of Fucidin® cream with Fucidin® cream vehicle in the treatment of impetigo in paediatric... | |||||||||||||
Medical condition: Patients with a clinical diagnosis of impetigo, aged 2-11 years, with a severity score of minimum 1 for at least one of the following signs: Pustules/infected bullae, erythema and infiltration/indu... | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002285-12 | Sponsor Protocol Number: OJ-KDC01 | Start Date*: 2019-12-02 |
Sponsor Name:LABORATORIO OJER PHARMA, S.L. | ||
Full Title: An exploratory, multicenter, randomized, open-label with blind evaluation, active-controlled study to evaluate the safety and efficacy of Keramod (imiquimod 50 mg/g, Gel) compared with Aldara (imi... | ||
Medical condition: ACTINIC QUERATOSIS, also known as solar keratosis, is a skin disease caused by chronic exposure to sunlight. It appears as scaly lesions on the skin as a result of an abnormal growth of the cells i... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001766-25 | Sponsor Protocol Number: CASM981CVE01 | Start Date*: 2017-09-28 |
Sponsor Name:Novartis | ||
Full Title: An open label, 52 week, multicenter study, of long term management to evaluate effectiveness, tolerability and safety of pimecrolimus cream 1% in pediatric patients with mild to moderate atopic der... | ||
Medical condition: mild to moderate atopic dermatitis | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2018-003615-22 | Sponsor Protocol Number: EXP-1373 | Start Date*: 2019-05-28 | |||||||||||
Sponsor Name:LEO Pharma A/S | |||||||||||||
Full Title: Efficacy and safety of twice-daily application of delgocitinib cream 20 mg/g for 6 weeks in subjects with active discoid lupus erythematosus. A phase 2a exploratory, randomised, double-blind, vehi... | |||||||||||||
Medical condition: Discoid lupus erythematosus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) DK (Prematurely Ended) FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
